Raymond G. Booth

1.7k total citations
70 papers, 1.4k citations indexed

About

Raymond G. Booth is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Raymond G. Booth has authored 70 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Biology, 42 papers in Cellular and Molecular Neuroscience and 10 papers in Organic Chemistry. Recurrent topics in Raymond G. Booth's work include Receptor Mechanisms and Signaling (40 papers), Neurotransmitter Receptor Influence on Behavior (22 papers) and Pharmacological Receptor Mechanisms and Effects (16 papers). Raymond G. Booth is often cited by papers focused on Receptor Mechanisms and Signaling (40 papers), Neurotransmitter Receptor Influence on Behavior (22 papers) and Pharmacological Receptor Mechanisms and Effects (16 papers). Raymond G. Booth collaborates with scholars based in United States, Netherlands and China. Raymond G. Booth's co-authors include Clinton E. Canal, Ross J. Baldessarini, Steven D. Wyrick, Drake Morgan, Neal Castagnoli, Hans Rollema, Neepa Choksi, Tania Córdova, Nader H. Moniri and Rob Leurs and has published in prestigious journals such as Brain Research, The FASEB Journal and Biochemical and Biophysical Research Communications.

In The Last Decade

Raymond G. Booth

68 papers receiving 1.4k citations

Peers

Raymond G. Booth

CMN

PHARM

Katharine Herrick‐Davis United States

David E. Nichols United States

Carine Bécamel France

Rita Raddatz United States

Bronwyn M. Kivell New Zealand

Seksiri Arttamangkul United States

Jean‐Paul Nicolas France

Richard Lovell United Kingdom

Ian T. Forbes United Kingdom

Petra Scholze Austria

Katharine Herrick‐Davis United States

Raymond G. Booth

1.7k ×2.0

1.4k ×1.8

CMN

208 ×1.0

159 ×1.0

140 ×1.4

PHARM

Citations per year, relative to Raymond G. Booth Raymond G. Booth (= 1×) peers Katharine Herrick‐Davis

Countries citing papers authored by Raymond G. Booth

Since Specialization

Citations

This map shows the geographic impact of Raymond G. Booth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raymond G. Booth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raymond G. Booth more than expected).

Fields of papers citing papers by Raymond G. Booth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raymond G. Booth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raymond G. Booth. The network helps show where Raymond G. Booth may publish in the future.

Co-authorship network of co-authors of Raymond G. Booth

This figure shows the co-authorship network connecting the top 25 collaborators of Raymond G. Booth. A scholar is included among the top collaborators of Raymond G. Booth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raymond G. Booth. Raymond G. Booth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cui, Meng, et al.. (2023). Conformationally Selective 2-Aminotetralin Ligands Targeting the alpha2A- and alpha2C-Adrenergic Receptors. ACS Chemical Neuroscience. 14(10). 1884–1895. 2 indexed citations

Cui, Meng, et al.. (2023). Development of 2-Aminotetralin-Type Serotonin 5-HT₁ Agonists: Molecular Determinants for Selective Binding and Signaling at 5-HT_1A, 5-HT_1B, 5-HT_1D, and 5-HT_1F Receptors. ACS Chemical Neuroscience. 15(2). 357–370. 1 indexed citations

Armstrong, Jessica, et al.. (2021). Evaluation of lorcaserin as an anticonvulsant in juvenile Fmr1 knockout mice. Epilepsy Research. 175. 106677–106677. 10 indexed citations

Cui, Meng, et al.. (2021). A new class of 5‐HT_2A/5‐HT_2C receptor inverse agonists: Synthesis, molecular modeling, in vitro and in vivo pharmacology of novel 2‐aminotetralins. British Journal of Pharmacology. 179(11). 2610–2630. 6 indexed citations

Armstrong, Jessica, et al.. (2020). (S)-5-(2′-Fluorophenyl)-N,N-dimethyl-1,2,3,4-tetrahydronaphthalen-2-amine, a Serotonin Receptor Modulator, Possesses Anticonvulsant, Prosocial, and Anxiolytic-like Properties in an Fmr1 Knockout Mouse Model of Fragile X Syndrome and Autism Spectrum Disorder. ACS Pharmacology & Translational Science. 3(3). 509–523. 20 indexed citations

Sakhuja, Rajeev, Krishnakanth Kondabolu, Tania Córdova, et al.. (2015). Novel 4-substituted-N,N-dimethyltetrahydronaphthalen-2-amines: synthesis, affinity, and in silico docking studies at serotonin 5-HT2-type and histamine H1 G protein-coupled receptors. Bioorganic & Medicinal Chemistry. 23(7). 1588–1600. 5 indexed citations

Canal, Clinton E., Drake Morgan, Krishnakanth Kondabolu, et al.. (2014). A Novel Aminotetralin-Type Serotonin (5-HT) 2C Receptor-Specific Agonist and 5-HT2A Competitive Antagonist/5-HT2B Inverse Agonist with Preclinical Efficacy for Psychoses. Journal of Pharmacology and Experimental Therapeutics. 349(2). 310–318. 22 indexed citations

Kasper, James M., et al.. (2013). The serotonin-2 receptor modulator, (-)-trans-PAT, decreases voluntary ethanol consumption in rats. European Journal of Pharmacology. 718(1-3). 98–104. 13 indexed citations

Morgan, Drake, Krishnakanth Kondabolu, Allison L. Kuipers, et al.. (2013). Molecular and behavioral pharmacology of two novel orally-active 5HT2 modulators: Potential utility as antipsychotic medications. Neuropharmacology. 72. 274–281. 18 indexed citations

10.

Canal, Clinton E., et al.. (2011). Drug discovery targeting human 5-HT2C receptors: Residues S3.36 and Y7.43 impact ligand—Binding pocket structure via hydrogen bond formation. European Journal of Pharmacology. 673(1-3). 1–12. 20 indexed citations

11.

Booth, Raymond G., et al.. (2009). (1R, 3S)-(−)-Trans-PAT: A novel full-efficacy serotonin 5-HT2C receptor agonist with 5-HT2A and 5-HT2B receptor inverse agonist/antagonist activity. European Journal of Pharmacology. 615(1-3). 1–9. 37 indexed citations

12.

Booth, Raymond G., Liangjuan Fang, Andrzej Wilczyński, et al.. (2008). Molecular determinants of ligand-directed signaling for the histamine H1 receptor. Inflammation Research. 57(S1). 43–44. 9 indexed citations

13.

Golbraikh, Alexander, et al.. (2006). Novel ligands for the human histamine H1 receptor: Synthesis, pharmacology, and comparative molecular field analysis studies of 2-dimethylamino-5-(6)-phenyl-1,2,3,4-tetrahydronaphthalenes. Bioorganic & Medicinal Chemistry. 14(19). 6640–6658. 38 indexed citations

14.

Heinzen, Erin L., Raymond G. Booth, & Gary M. Pollack. (2005). Neuronal nitric oxide modulates morphine antinociceptive tolerance by enhancing constitutive activity of the μ-opioid receptor. Biochemical Pharmacology. 69(4). 679–688. 27 indexed citations

15.

Booth, Raymond G., Nader H. Moniri, Remko A. Bakker, et al.. (2002). A Novel Phenylaminotetralin Radioligand Reveals a Subpopulation of Histamine H1 Receptors. Journal of Pharmacology and Experimental Therapeutics. 302(1). 328–336. 19 indexed citations

16.

Booth, Raymond G., et al.. (1999). Putative σ3 sites in mammalian brain have histamine H1 receptor properties: evidence from ligand binding and distribution studies with the novel H1 radioligand [ ]-(−)-trans-1-phenyl-3-aminotetralin. Brain Research. 837(1-2). 95–105. 15 indexed citations

17.

Booth, Raymond G. & Ross J. Baldessarini. (1991). (+)-6,7-Benzomorphan sigma ligands stimulate dopamine synthesis in rat corpus striatum tissue. Brain Research. 557(1-2). 349–352. 49 indexed citations

18.

Booth, Raymond G. & Ross J. Baldessarini. (1990). Adenosine A2 stimulation of tyrosine hydroxylase in rat striatal minces is reversed by dopamine D2 autoreceptor activation. European Journal of Pharmacology. 185(2-3). 217–221. 13 indexed citations

19.

Booth, Raymond G., Anthony J. Trevor, Thomas P. Singer, & Neal Castagnoli. (1989). Studies on semirigid tricyclic analogs of the nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Journal of Medicinal Chemistry. 32(2). 473–477. 20 indexed citations

20.

Booth, Raymond G., et al.. (1988). Selective inhibition of Leishmania dihydrofolate reductase and Leishmania growth by 5-benzyl-2,4-diaminopyrimidines. Molecular and Biochemical Parasitology. 31(1). 79–85. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact